Birdwatch Note Rating
2023-03-15 21:00:36 UTC - NOT_HELPFUL
Rated by Participant: 7D3FC656C9BBB23DBC215B9645C9F318DD16E265528F7B8B22BD48E7B9C15059
Participant Details
Original Note:
From a GAO report on mifepristone: "FDA approved the drug under a provision of the agency’s Subpart H regulations … titled “Accelerated Approval of New Drugs". The regulation "provides FDA with flexibilities that allow the agency to accelerate the approval process" https://www.gao.gov/assets/gao-08-751.pdf
All Note Details